- Home
- Responsibility
- Commitment to transparency
- Patient group funding
- International groups
Patient group funding
GSK Pharmaceuticals Emerging Markets and Asia Pacific (EMAP) Region covers seven geographical areas - Middle East and Africa, Latin America, CIS, South Asia, Developing Countries, Asia Pac and China. Details of GSK funding provided to patient groups working in EMAP in 2010 are listed below.
Patient grant data
Detailed information for Australia and Canada can be found on their website.
Information for Japan can be obtained directly from the Japanese office.
